VKTX logo

Viking Therapeutics, Inc. (VKTX) Free Cash Flow

Annual FCF:

-$87.79M-$14.41M(-19.64%)
December 31, 2024

Summary

  • As of today, VKTX annual free cash flow is -$87.79 million, with the most recent change of -$14.41 million (-19.64%) on December 31, 2024.
  • During the last 3 years, VKTX annual free cash flow has fallen by -$40.20 million (-84.49%).
  • VKTX annual free cash flow is now -175480.00% below its all-time high of -$50.00 thousand, reached on December 31, 2012.

Performance

VKTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

Quarterly FCF:

-$47.06M+$5.27M(+10.07%)
June 30, 2025

Summary

  • As of today, VKTX quarterly free cash flow is -$47.06 million, with the most recent change of +$5.27 million (+10.07%) on June 30, 2025.
  • Over the past year, VKTX quarterly free cash flow has dropped by -$18.55 million (-65.05%).

Performance

VKTX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

TTM FCF:

-$152.53M-$18.55M(-13.84%)
June 30, 2025

Summary

  • As of today, VKTX TTM free cash flow is -$152.53 million, with the most recent change of -$18.55 million (-13.84%) on June 30, 2025.
  • Over the past year, VKTX TTM free cash flow has dropped by -$80.59 million (-112.02%).

Performance

VKTX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

VKTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-19.6%-65.0%-112.0%
3Y3 Years-84.5%-250.1%-222.8%
5Y5 Years-254.7%-606.0%-444.1%

VKTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-84.5%at low-667.2%+10.1%-215.2%at low
5Y5-Year-303.1%at low-784.1%+10.1%-600.4%at low
All-TimeAll-Time>-9999.0%at low>-9999.0%+10.1%>-9999.0%at low

VKTX Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$47.06M(+10.1%)
-$152.53M(-13.8%)
Mar 2025
-
-$52.33M(-67.8%)
-$133.99M(-52.6%)
Dec 2024
-$87.79M(-19.6%)
-$31.18M(-42.0%)
-$87.79M(-18.2%)
Sep 2024
-
-$21.96M(+23.0%)
-$74.25M(-3.2%)
Jun 2024
-
-$28.51M(-364.8%)
-$71.94M(-31.1%)
Mar 2024
-
-$6.13M(+65.2%)
-$54.87M(+25.2%)
Dec 2023
-$73.38M(-51.6%)
-$17.64M(+10.3%)
-$73.38M(-10.1%)
Sep 2023
-
-$19.66M(-71.9%)
-$66.66M(-10.2%)
Jun 2023
-
-$11.44M(+53.6%)
-$60.50M(+3.2%)
Mar 2023
-
-$24.64M(-125.5%)
-$62.51M(-29.2%)
Dec 2022
-$48.40M(-1.7%)
-$10.93M(+19.1%)
-$48.40M(+2.9%)
Sep 2022
-
-$13.50M(-0.4%)
-$49.82M(-5.4%)
Jun 2022
-
-$13.44M(-27.7%)
-$47.25M(-0.0%)
Mar 2022
-
-$10.53M(+14.7%)
-$47.24M(+0.7%)
Dec 2021
-$47.59M(-118.5%)
-$12.35M(-13.0%)
-$47.59M(-16.9%)
Sep 2021
-
-$10.93M(+18.7%)
-$40.72M(-16.0%)
Jun 2021
-
-$13.43M(-23.5%)
-$35.12M(-23.9%)
Mar 2021
-
-$10.88M(-98.3%)
-$28.35M(-30.2%)
Dec 2020
-$21.78M(+12.0%)
-$5.49M(-3.1%)
-$21.78M(+22.3%)
Sep 2020
-
-$5.32M(+20.1%)
-$28.03M(-7.4%)
Jun 2020
-
-$6.67M(-55.0%)
-$26.11M(-0.8%)
Mar 2020
-
-$4.30M(+63.4%)
-$25.90M(-4.6%)
Dec 2019
-$24.75M
-$11.74M(-245.6%)
-$24.75M(-57.8%)
Sep 2019
-
-$3.40M(+47.4%)
-$15.69M(+11.8%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$6.46M(-104.9%)
-$17.79M(-7.2%)
Mar 2019
-
-$3.15M(-17.7%)
-$16.60M(+11.5%)
Dec 2018
-$18.75M(-27.1%)
-$2.68M(+51.3%)
-$18.75M(+6.3%)
Sep 2018
-
-$5.50M(-4.4%)
-$20.02M(-12.2%)
Jun 2018
-
-$5.27M(+0.6%)
-$17.85M(-6.4%)
Mar 2018
-
-$5.30M(-34.3%)
-$16.78M(-13.7%)
Dec 2017
-$14.76M(-33.3%)
-$3.95M(-18.6%)
-$14.76M(-11.2%)
Sep 2017
-
-$3.33M(+20.8%)
-$13.27M(-5.3%)
Jun 2017
-
-$4.20M(-28.2%)
-$12.60M(-8.4%)
Mar 2017
-
-$3.28M(-33.0%)
-$11.62M(-5.0%)
Dec 2016
-$11.07M(-26.8%)
-$2.46M(+7.1%)
-$11.07M(+7.0%)
Sep 2016
-
-$2.65M(+17.7%)
-$11.91M(+5.9%)
Jun 2016
-
-$3.23M(-18.4%)
-$12.65M(-14.5%)
Mar 2016
-
-$2.73M(+17.4%)
-$11.05M(-26.5%)
Dec 2015
-$8.73M(-448.7%)
-$3.30M(+3.0%)
-$8.73M(-60.7%)
Sep 2015
-
-$3.40M(-109.8%)
-$5.43M(-167.4%)
Jun 2015
-
-$1.62M(-294.4%)
-$2.03M(-139.5%)
Mar 2015
-
-$410.90K(+6.1%)
-$848.30K(-57.6%)
Dec 2014
-$1.59M(-1935.0%)
-
-
Jun 2014
-
-$437.40K(-333.9%)
-$538.20K(-386.2%)
Mar 2014
-
-$100.80K(-918.2%)
-$110.70K(-1018.2%)
Dec 2013
-$78.20K(-56.4%)
-
-
Jun 2013
-
-$9900.00(>-9900.0%)
-$9900.00(>-9900.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
-$50.00K
-
-

FAQ

  • What is Viking Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Viking Therapeutics, Inc.?
  • What is Viking Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Viking Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Viking Therapeutics, Inc.?
  • What is Viking Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Viking Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Viking Therapeutics, Inc.?
  • What is Viking Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Viking Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of VKTX is -$87.79M

What is the all-time high annual free cash flow for Viking Therapeutics, Inc.?

Viking Therapeutics, Inc. all-time high annual free cash flow is -$50.00K

What is Viking Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, VKTX annual free cash flow has changed by -$14.41M (-19.64%)

What is Viking Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of VKTX is -$47.06M

What is the all-time high quarterly free cash flow for Viking Therapeutics, Inc.?

Viking Therapeutics, Inc. all-time high quarterly free cash flow is $0.00

What is Viking Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, VKTX quarterly free cash flow has changed by -$18.55M (-65.05%)

What is Viking Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of VKTX is -$152.53M

What is the all-time high TTM free cash flow for Viking Therapeutics, Inc.?

Viking Therapeutics, Inc. all-time high TTM free cash flow is $0.00

What is Viking Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, VKTX TTM free cash flow has changed by -$80.59M (-112.02%)
On this page